BeOne Medicines Ltd.
Close on Nov 2, 2026Market cap $41.08BP/E 64.6Yield –
BeOne Medicines Profit-Share & Collaboration Reimbursement Expense by Year
Profit-Share & Collaboration Reimbursement Expense — Total Net ($M) ($M)
BeOne Medicines Profit-Share & Collaboration Reimbursement Expense: $66.6M in FY2025, down 235.9% from a year earlier.
Where the FY2025 figure comes from
Source: Form 10-K (filed 2026-02-26) ↗
Reported in Form 10-Q / 10-K Collaborative Arrangements Note (XBRL).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Profit-Share & Collaboration Reimbursement Expense — Total Net ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 66.6 | -235.9% | Form 10-K (filed 2026-02-26) ↗ |
| FY2024 | Dec 31, 2024 | -49 | -3.7% | Form 10-K (filed 2026-02-26) ↗ |
| FY2023 | Dec 31, 2023 | -50.9 | -201.4% | Form 10-K (filed 2026-02-26) ↗ |
| FY2022 | Dec 31, 2022 | 50.2 | +17.3% | Form 10-K (filed 2025-02-27) ↗ |
| FY2021 | Dec 31, 2021 | 42.8 | +269.0% | Form 10-K (filed 2024-02-26) ↗ |
| FY2020 | Dec 31, 2020 | 11.6 | – | Form 10-K (filed 2023-02-27) ↗ |
Breakdown
What makes up profit-Share & Collaboration Reimbursement Expense
Cite this data
StockData. (2026). BeOne Medicines Profit-Share & Collaboration Reimbursement Expense ($M), annual FY2020–FY2025 [Data set]. Compiled from BeOne Medicines SEC filings and investor materials. https://stockdatahq.com/stocks/onc/kpis/reimb-tot
See every metric in the BeOne Medicines KPI table. Data updated Oct 29, 2026.